{"product_id":"ucsf-the-medical-management-of-aids-and-key-infections-2024","title":"UCSF The Medical Management of AIDS and Key Infections 2024","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch3\u003eUCSF The Medical Management of AIDS and Key Infections 2024\u003c\/h3\u003e\n\u003cstrong\u003e Include: 33 videos + 28 pdfs, size: 22.1 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: infectious disease specialists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis course provides the active, intermediate-to-advanced clinician with a comprehensive review of the science of HIV and key infections including Hepatitis, RSV and COVID, as well as an update on the application of appropriate therapies. For ambitious new clinicians who want a challenge, we still offer our New Clinicians Track (NCT). This track provides five additional lectures that cover antiretroviral therapy (ART) 101, basic HIV pharmacology, management of ART resistance, IRIS, and opportunistic infections. All course lecturers are leading clinicians and teachers who are dedicated to teaching in their areas of expertise.\u003cbr\u003e\u003cbr\u003eAcute and Long COVID continue to amplify existing health disparities and contribute to the vulnerability of all of our patients, making the need for up-to-date information about HIV\/AIDS, HCV, HBV, add RSV, COVID and other key infections essential for providing high quality care. Current treatment options for acute COVID and understanding the science and management of Long COVID will be addressed.\u003cbr\u003e\u003cbr\u003eAll lectures will be cased-based with at least 2-4 ARS questions per session. Question and answer time as well as faculty panels are weaved into each conference day. The panels are designed with ARS questions so that you can privately test your individual knowledge against the experts throughout the conference. Questions that arise in the Chat will be answered throughout each conference day by our enthusiastic faculty\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEDUCATIONAL OBJECTIVES\u003c\/strong\u003e\u003cbr\u003eAn attendee completing this course will have improved skills and strategies to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e Diagnose, treat, and prevent important conditions in HIV medicine and HIV medicine subspecialties, for improved patient outcomes;\u003cbr\u003e Apply in practice the latest treatment guidelines and recommendations for the prevention of HIV transmission and the appropriate use of PEP, PrEP, and DoxyPEP;\u003cbr\u003e Apply new recommendations for initiating and timely switching of antiretroviral combinations, and the use of long-acting therapy in appropriate patients;\u003cbr\u003e Identify the new developments and apply treatment recommendations in HIV related GI, cardiac, psychiatric and dermatologic disease as well as addiction medicine;\u003cbr\u003e Apply new recommendations for the treatment of HCV, HBV, cirrhosis, MASH and MAFLD.\u003cbr\u003e Align practice patterns more with current evidence and guidelines for treating STI’s, and HIV.\u003cbr\u003e Apply in practice the recommendations for the prevention of RSV, H5N1, and COVID transmission and the updated treatment guidelines for RSV, H5N1, and COVID\u003cbr\u003e Apply new recommendations for appropriate treatment of acute COVID and Long COVID\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDay 1 Cases \u0026amp; Challenges with ART.mp4\u003cbr\u003eDay 1 Cases \u0026amp; Controversies in PEP, PrEP \u0026amp; DoxyPEP.mp4\u003cbr\u003eDay 1 Cases \u0026amp; Controversies in PEP, PrEP \u0026amp; DoxyPEP.pdf\u003cbr\u003eDay 1 Great Cases from the Bay.mp4\u003cbr\u003eDay 1 Great Cases from the Bay.pdf\u003cbr\u003eDay 1 HIV Neurology Cases.pdf\u003cbr\u003eDay 1 Introduction.mp4\u003cbr\u003eDay 1 Introduction.pdf\u003cbr\u003eDay 1 Introductory Remarks.mp4\u003cbr\u003eDay 1 NCTNew Clinicians Workshop ART101 Antiretroviral Therapy Initiation From Guidelines to Practice.mp4\u003cbr\u003eDay 1 NCTNew Clinicians Workshop ART101 Antiretroviral Therapy Initiation From Guidelines to Practice.pdf\u003cbr\u003eDay 1 Opportunities and Challenges in STI Prevention and Treatment.mp4\u003cbr\u003eDay 1 Opportunities and Challenges in STI Prevention and Treatment.pdf\u003cbr\u003eDay 1 Q\u0026amp;A Prevention Panel Q\u0026amp;A.mp4\u003cbr\u003eDay 1 Rapid Fire Derm for Primary Care.pdf\u003cbr\u003eDay 1 The Leading Edge of Prevention.mp4\u003cbr\u003eDay 1 The Leading Edge of Prevention.pdf\u003cbr\u003eDay 1 The Long and Short of Long-Acting Formulations.mp4\u003cbr\u003eDay 1 The Long and Short of Long-Acting Formulations.pdf\u003cbr\u003eDay 1 The State of the Art of ART.mp4\u003cbr\u003eDay 1 Ton Ten Issues in HIV Medicine.mp4\u003cbr\u003eDay 1 Top Ten Issues in HIV Medicine.pdf\u003cbr\u003eDay 1 What’s New about HIV Cure.mp4\u003cbr\u003eDay 1 What’s New about HIV Cure.pdf\u003cbr\u003eDay 2 Cases from the STI Clinic in 2024.mp4\u003cbr\u003eDay 2 ID Pearls for HIV Providers.pdf\u003cbr\u003eDay 2 Managing Long COVID- What’s New.mp4\u003cbr\u003eDay 2 Managing Long COVID- What’s New.pdf\u003cbr\u003eDay 2 Navigating Outpatient COVID-19 Treatment Options.mp4\u003cbr\u003eDay 2 Navigating Outpatient COVID-19 Treatment Options.pdf\u003cbr\u003eDay 2 NCT Cases from the Inpatient HIV Service- OI’s and IRIS.mp4\u003cbr\u003eDay 2 NCT Cases from the Inpatient HIV Service- OI’s and IRIS.pdf\u003cbr\u003eDay 2 NCTIntroduction to ARV Drug Resistance.mp4\u003cbr\u003eDay 2 Prevention of anal cancer in people with HIV- new guidelines in 2024.mp4\u003cbr\u003eDay 2 Prevention of anal cancer in people with HIV- new guidelines in 2024.pdf\u003cbr\u003eDay 2 Respiratory Panel.mp4\u003cbr\u003eDay 2 RSV Across The Life Span- what’s new.mp4\u003cbr\u003eDay 2 RSV Across The Life Span- what’s new.pdf\u003cbr\u003eDay 2 The Building Blocks of HIV Therapy.mp4\u003cbr\u003eDay 2 The Building Blocks of HIV Therapy.pdf\u003cbr\u003eDay 2 Updates on H5N1 Influenza.mp4\u003cbr\u003eDay 2 Updates on H5N1 Influenza.pdf\u003cbr\u003eDay 2 Weight Management- Cases from the Clinic.mp4\u003cbr\u003eDay 2 Weight Management- Cases from the Clinic.pdf\u003cbr\u003eDay 2 What’s New in Endocrinology in 2024.mp4\u003cbr\u003eDay 2 What’s New in Endocrinology in 2024.pdf\u003cbr\u003eDay 2 What’s New in Transgender Care.pdf\u003cbr\u003eDay 3 Case Based Psychiatry.mp4\u003cbr\u003eDay 3 Case Based Psychiatry.pdf\u003cbr\u003eDay 3 Cases in Addiction Medicine and Pain Management.mp4\u003cbr\u003eDay 3 Cases in Addiction Medicine and Pain Management.pdf\u003cbr\u003eDay 3 HIV-associated Pulmonary Disease Classic and Challenging Cases for the Clinician, 2024.pdf\u003cbr\u003eDay 3 Interactive Panel Psychiatry \u0026amp; Managing Substance Use and Pain.mp4\u003cbr\u003eDay 3 Introduction.mp4\u003cbr\u003eDay 3 Liver Panel with Q\u0026amp;A.mp4\u003cbr\u003eDay 3 Substance use trends in the US- What providers need to know.mp4\u003cbr\u003eDay 3 Substance use trends in the US- What providers need to know.pdf\u003cbr\u003eDay 3 The Heart of the Matter of Cardiology.pdf\u003cbr\u003eDay 3 Updates from the Hepatitis Clinic MASLD, MASH, and More.mp4\u003cbr\u003eDay 3 Updates on HBV from the HIV Clinic.mp4\u003cbr\u003eDay 3 Updates on HBV from the HIV Clinic.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954496868450,"sku":"MED-AMB04622","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UCSF-The-Medical-Management-of-AIDS-and-Key-Infections-2024.jpg?v=1779378062","url":"https:\/\/meducourse.com\/products\/ucsf-the-medical-management-of-aids-and-key-infections-2024","provider":"Meducourse","version":"1.0","type":"link"}